Neogenomics Inc (NEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Sales | 34,371 | 29,469 | 20,015 | 11,505 | 6,476 |
| Cost of Goods | 18,588 | 14,254 | 9,354 | 5,523 | 2,759 |
| Gross Profit | 15,783 | 15,215 | 10,662 | 5,982 | 3,717 |
| Operating Expenses | 19,334 | 17,197 | 11,899 | 9,646 | 4,336 |
| Operating Income | -2,963 | -1,728 | -884 | -3,141 | 140 |
| Interest Expense | 710 | 532 | 309 | 264 | 326 |
| Other Income | 370 | 17 | -190 | 24 | 56 |
| Pre-tax Income | -3,303 | -2,243 | -1,383 | -3,380 | -130 |
| Net Income Continuous | -3,303 | -2,243 | -1,383 | -3,380 | -130 |
| Net Income | $-3,303 | $-2,243 | $-1,383 | $-3,380 | $-130 |
| EPS Basic Total Ops | -0.09 | -0.06 | -0.04 | -0.11 | 0.00 |
| EPS Basic Continuous Ops | -0.09 | -0.06 | -0.04 | -0.11 | -0.01 |
| EPS Diluted Total Ops | -0.09 | -0.06 | -0.04 | -0.11 | 0.00 |
| EPS Diluted Continuous Ops | -0.09 | -0.06 | -0.04 | -0.11 | -0.01 |
| EBITDA(a) | $-1,133 | $-475 | $-89 | $-2,635 | $447 |